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ABSTRACT  
Objective: Examine responses given to questions addressing whether pregnancy had caused women with 
nausea and vomiting (NVP) or symptom-free (SF) to alter their food habits in the first trimester in order to 
better understand the dietary changes taking place in women with NVP. 
Method: Using questions featured in the Norwegian Mother and Child Cohort Study (MoBa) specifically 
asking participants about alterations in diet and episodes of nausea and vomiting. The final sample used 
included 30,072 women. 
Results: We found 46% with no symptoms of nausea and/or vomiting in pregnancy, whilst 54% reported 
both nausea and vomiting. The NVP group of women were the group most affected with changes in food 
consumption, having the lowest proportion reporting to eat as before pregnancy, as well as the highest 
proportion reporting ‘eating more’ and ‘reduced eating’. The SF group reported eating more than NVP 
group in one instance, that being for chocolate (SF 17.7% vs NVP 16.3%). 
Conclusion: We have shown a higher degree of dietary change in women with NVP compared to SF 
women. We also found chocolate as the only exception, with a higher proportion of SF women eating more 
of this food item. 
 
This is an open access article distributed under the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction 
in any medium, provided the original work is properly cited. 
 
 
INTRODUCTION 
 
Over half of all pregnancies involve episodes of nausea 
and vomiting (NVP), usually experienced during the 
first trimester (1,2). It is common during pregnancy for 
women to change the composition and quantity of their 
ordinary diet, usually as a result of food cravings and 
aversions (3,4). These dietary changes have been re-
ported to be more pronounced when NVP was present, 
yet little is understood about how dietary intake during 
pregnancy is actually affected by NVP (5). 
 In a study exploring the association between NVP 
symptoms and dietary preferences, cravings, and aver-
sions, it was reported that women with moderate to 
severe NVP had more cravings both before and during 
their pregnancy, although food aversions also tended 
to increase (6,7). 
 Previously reported cravings for foods include 
sweets (especially chocolate), fruits and fruit juices, 
ice cream, milk, and other dairy products (8), whereas 
the most commonly reported aversions were for drinks 
containing caffeine, strong tasting and smelling foods, 
and fatty/greasy foods (4). 
 We recently assessed the dietary intake of NVP 
women included in the Norwegian Mother and Child 
Cohort study (MoBa) and found a higher total energy 
intake for them compared to symptom-free (SF) women 
(9). In the present study we examined in more detail 
the responses given to specific questions addressing 
whether women enrolled in MoBa had altered their 
food habits in the first trimester. Furthermore, we in-
vestigated which food items, if any, the NVP group of 
women had altered their eating habits the most for in 
order to better understand the dietary changes taking 
place in women with first trimester NVP. 
 
 
MATERIAL AND METHODS 
 
The core data of this study is based on the Norwegian 
Mother and Child Cohort Study (MoBa) (10). Data re-
garding age (year), height (cm), weight (kg), education 
(seven categories collapsed into: ≤12 years, 13-16 
years, ≥17 years of education, other education or mis-
sing), and maternal smoking (no, occasionally, daily) 
were obtained from data found in MoBa questionnaire 
1 (Q1), answered approximately in week 15 of gesta-
tion. Maternal body mass index (BMI, kg/m2) was 
calculated at the start of pregnancy. The Medical Birth 
Registry of Norway (MBRN) is linked to MoBa (11) 
and parity data from the MBRN and questions detail-
ing previously occurring pregnancies from Q1 were 
combined in order to minimise missing values. We 
used three categories for parity (nulliparous, para 1, 
para ≥2). Within version 1 of questionnaire 2 (Q2), 
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answered between weeks 15 to 22 of gestation, was a 
validated food frequency questionnaire (FFQ), and in 
version 2 of Q2, additional questions regarding dietary 
behaviour and episodes of nausea and vomiting. The 
FFQ allowed us to calculate energy intake (kJ), macro-
nutrient intake (g), and micronutrient intake (mg/µg). 
Energy percent (E%) of macronutrients were calculated 
using overall energy intake and specific macronutrient 
intake values. In question 31 (q31) within Q2, women 
were asked to indicate which food items they had 
started to eat more of, less of, as before, never eaten 
before, or else stopped eating completely due to the 
pregnancy, ticking boxes in a list provided. Ques-
tionnaire three (Q3) provided data enabling us to deter-
mine cases diagnosed as Hyperemesis Gravidarum 
(HG), defined as prolonged nausea and vomiting 
during pregnancy that required hospitalisation before 
week 25 of pregnancy. Gestational weight gain 
(GWG) was calculated as weight at end of pregnancy 
(from questionnaire four (Q4) minus maternal weight 
at start of pregnancy (from Q1). Q4, answered post-
partum, had a lower response rate compared with Q1 
or Q2. Owing to this, there are data missing for 5112 
women (17% of sample) regarding GWG. In the 
analysis of GWG, only women with gestational weight 
changes between –30 kg and +50 kg were included. 
The present study used the quality-assured data files 
released for research in 2009 (version four). 
 
Study sample  
The MoBa cohort featured in the version four data file 
used here consists of 108,842 children. The present 
study excluded women with multiple births, those not 
answering Q1 or only version one of Q2 (n=17,995). 
Further exclusions were made for women failing to 
answer version 2 of Q2 (n=5390). Women not 
answering questions relating to episodes of nausea and 
vomiting, or reporting only nausea or only vomiting, 
HG, a duration of nausea and vomiting >26 weeks, or 
a dietary intake ≤4500 or ≥20,000 kJ were also exclu-
ded (n=25,769). Reports of NVP were cross-checked 
from answers provided in both Q1 and Q2, with exclu-
sions made for inconsistent or contradicting answers 
between the two questionnaires, or with contradicting 
answers such as simultaneously answering both ‘yes’ 
and ‘no’ to nausea and vomiting (n=15,791). Women 
enrolled in MoBa more than once due to additional 
pregnancies had all but their first participation excluded 
(n=9699). Women with a gestational length outside 
weeks 28-42, women without a successful pregnancy 
(i.e. non-living births), and those with missing weight 
and height at the start of pregnancy were excluded 
(n=2894). Finally, women not answering q31 of Q2 
were excluded (n=1232). In total, 30,072 women were 
included in the final study sample. 
 
Statistical analysis  
The study sample was divided into two groups, reflec-
ting answers concerning experiences of nausea and 
vomiting: having both nausea and vomiting (NVP) or 
symptom-free (SF). Results are presented as means 
(standard deviations; SDs) or frequencies (%). In-
dependent samples t-test was used to compare means 
between the two groups. Chi-squared tests were per-
formed for categorical variables. Logistic regression 
analysis was used to analyse binary outcomes (eating 
more, reduced intake) in relation to group (SF, NVP). 
We adjusted for energy intake (continuous). The 
results are presented as crude odds ratios (cORs) and 
adjusted odds ratios (aORs) with 95% confidence 
intervals (95% CIs). In order to effectively explore 
which foods the women had begun to actually eat less 
of, we combined data for foods reported as ‘eating less 
of’ as well as ‘stopped completely’ in pregnancy, to 
create a category showing overall reduced intake in the 
logistic regression analyses. A significance level of 
0.05 was used. All analyses were performed using 
SPSS 20.0 (IBM Corp, Armonk, NY, USA). 
 
RESULTS 
 
In this study sample, 46% reported no symptoms of 
nausea and vomiting in pregnancy (SF group, 
n=13,371), whilst 54% reported both nausea and vomi-
ting (NVP group, n=16,341). The NVP group had the 
lowest mean maternal age at delivery, highest mean 
weight and BMI at the start of pregnancy, lowest mean 
gestational weight gain (GWG) at end of pregnancy, 
lowest proportion nulliparous, highest proportions with 
education ≤12 years, highest proportions being non-
smokers before and during pregnancy, highest mean 
energy intake and micronutrient intake, highest mean 
energy percent (E%) intakes of carbohydrates and 
added sugar, and lowest mean E% intakes of protein 
and fat (Table 1). 
 The NVP group was the group most affected by 
overall changes in food consumption when compared 
to the SF group, portrayed by their representing the 
lowest proportion reporting to eat ‘as before preg-
nancy’ (Table 2). Moreover, the NVP group had the 
highest proportions eating ‘more of’ and the highest 
proportions eating ‘less of’ and ‘stopped’. The only 
exception was chocolate, where the proportion eating 
‘more of’ was lower for NVP than SF women. When 
exploring foods eaten ‘more of’, significant differen-
ces between the NVP group and SF group were found 
for all foods except sweets (Table 3). The largest 
differences were found for biscuits (aOR 2.69, 95% CI 
2.48-2.91), eggs (aOR 1.59, 95% CI 1.47-1.72), and 
sugared soft-drinks (aOR 1.92, 95% CI 1.75-2.11). 
Significantly less NVP women reported eating more 
chocolate (aOR 0.88, 95% CI 0.83-0.94). Significantly 
increased odds were found for all foods when com-
paring NVP women to SF women as regards reduced 
intakes (Table 4). The largest differences between the 
two groups were for milk and cheese (aOR 4.70, 95% 
CI 4.14-5.13), bread and cereals (aOR 6.69, 95% CI 
5.63-7.94), vegetables (aOR 5.70, 95% CI 4.69-6.92), 
fruit (aOR 5.15, 95% CI 4.03-6.59), and meat (aOR 
3.48, 95% CI 3.19-3.81). 
DIETARY CHANGES IN PREGNANCY  149 
 
Table 1.  Maternal characteristics, n=30,072*. 
 
* Detailed characteristics from main sample can be found in our previous publication (9) 
** T-test for continuous variables and chi-squared test for categorical variables 
*** T-test for E% 
 
 
DISCUSSION 
 
The results presented in this article add new know-
ledge about dietary habits for women experiencing 
NVP in the first trimester of pregnancy. We found that 
NVP women had the greater dietary change compared 
to the SF women, representing the lowest proportion 
‘eating as before’ for all food items, as well as repre-
senting the highest proportion both ‘eating more’ and 
with ‘reduced eating’ for most food items. 
 In the MoBa questionnaires there were no specific 
questions to help us determine whether an increase of 
any particular food or food item could be interpreted 
as a craving, likewise, a reduced intake interpreted as 
an aversion. However, since it has been reported that 
approximately 50% of pregnant women experience 
cravings and 70% experience aversions (7,12), and 
that women with food cravings are more likely to 
experience NVP (12), we can speculate with a degree 
of caution that these food changes are related to 
cravings and aversions. It should nevertheless be noted 
that there are an abundance of other reasons why a 
woman may alter her diet during gestation, such as 
compliance with health service recommendations, 
fears for the wellbeing of the developing foetus, 
beliefs in folklore related to food combinations, and 
other socio-cultural determinants (13-15). 
 It has been suggested previously that women with 
symptoms of NVP may be turning to particular foods 
in an attempt to alleviate symptoms related to the un-
pleasantness of the condition (2,12,13,16). This is 
supported by research proposing foods, in particular 
carbohydrates, are often used to self-medicate in order 
to reduce unpleasant states of being, primarily via 
serotonin increases after consumption (17). We have 
previously reported that NVP women in MoBa have 
higher intakes of carbohydrates and added sugar than 
SF women (9). In the present study we found that 
carbohydrate-rich foods such as breads and cereals, 
sugared soft-drinks, and biscuits were foods the NVP 
women had high odds of eating more of. That women 
suffering from NVP increase their intake of bread, 
biscuits, and sweet sugar-containing foods during 
pregnancy, as well as total carbohydrates, has been 
  
Total 
n=30,072 
Symptom-free  
(SF) 
n=13,731 
Nausea and vomiting  
(NVP) 
n=16,341 
 
 
P value** 
 n Mean (SD) Mean (SD)  
Maternal age at delivery (y) 30,072 30.3 (4.5) 29.2 (4.6) <0.001 
Maternal weight at pregnancy start (kg) 30,072   67.5 (12.2)   68.6 (13.6) <0.001 
BMI at pregnancy start (kg/m²) 30,072 23.8 (4.1) 24.3 (4.6) <0.001 
Gestational weight gain (kg) 24,960 15.1 (5.7) 14.3 (6.4) <0.001 
  n (%) n (%)  
Parity 
     Nulliparous 
     Para 1 
     Para ≥2 
 
17,346 
8381 
4327 
 
8644 (63.0) 
3262 (23.8) 
1816 (13.2) 
 
8702 (53.3) 
5119 (31.3) 
2511 (15.4) 
 
 
<0.001 
Maternal education (y) 
     ≤12 y 
     13-16 y 
     ≥17 y 
 
9404 
12,541 
7470 
 
3987 (29.7) 
5761 (42.9) 
3673 (27.4) 
 
5417 (33.9) 
6780 (42.4) 
3797 (23.7) 
 
 
<0.001 
Smoking 3 months prior to pregnancy 
     No 
     Occasionally 
     Daily 
 
21,154 
3072 
5588 
 
9254 (68.0) 
1494 (11.0) 
2868 (21.0) 
 
11,900 (73.5) 
1578 (9.7) 
2720 (16.8) 
 
 
<0.001 
Smoking during pregnancy 
     No 
     Occasionally 
     Daily 
 
27,361 
  840 
1663 
 
12,259 (89.9) 
483 (3.5) 
899 (6.6) 
 
15,102 (93.1) 
357 (2.2) 
764 (4.7) 
 
 
<0.001 
 Mean (SD) E% Mean (SD) E%  
Energy (kJ) 9540.7 (2523.0) -   9828.4 (2713.7) - - 
Carbohydrates (g) 301.9 (90.5) 53.5 (4.7) 315.3 (97.6) 54.3 (5.0) <0.001*** 
Added sugar (g)   60.0 (37.1) 10.4 (4.8)   65.7 (42.5) 11.0 (5.4) <0.001*** 
Protein (g)   86.2 (20.8) 15.6 (2.1)   87.2 (22.4) 15.3 (2.2) <0.001*** 
Fat (g)   79.0 (23.6) 30.7 (4.5)   80.2 (25.3) 30.2 (4.6) <0.001*** 
Retinol (µg)   833.8 (619.4) -   860.8 (679.8) - <0.001 
Folate (µg) 271.9 (94.4) -   279.4 (101.8) - <0.001 
Vitamin D (µg)   3.4 (2.3) -   3.5 (2.5) - 0.02 
Iron (mg) 11.2 (3.4) - 11.4 (3.6) - <0.001 
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Table 2.  Overall food changes in the SF and NVP groups, n=30,072. 
 
  
Group 
Not eat before 
%  
As before 
%  
More of 
%  
Less of 
%  
Stopped 
%  
Milk, cheese SF 1.9  57.9  38.0    2.1  0.1  
NVP 2.6  46.4  41.7    8.9  0.4  
Bread, Cereals 
 
SF 0.1  66.6  32.1    1.1  0 
NVP 0.2 55.9  37.3    6.6  0 
Biscuits SF 11.8  67.0    6.4  13.8  0.9  
NVP 10.0  53.6  15.8  18.5  2.1  
Fat SF 4.7  77.3    3.6  14.2  0.2  
 NVP 4.7 64.9    4.7  24.9  0.7  
Meat 
 
SF 0.8  90.6    3.7    4.8  0  
NVP 1.2  78.5    5.5  14.6  0.3  
Fish 
 
SF 2.0  78.7  16.0    3.1  0.2  
NVP 2.6  70.0  17.1    9.8  0.6  
Eggs 
 
SF 1.7  84.2    7.5    6.3  0.2  
NVP 1.7 71.8  11.6  13.9  1.0  
Vegetables 
 
SF 0.2  66.6  32.3    0.9  0  
NVP 0.3 59.9  35.1    4.6  0.1  
Fruit 
 
SF 0.3  40.3  58.8    0.5  0  
NVP 0.3 33.4  63.7    2.6  0.1  
Chocolate 
 
SF 1.2  55.1  17.7  25.3  0.7  
NVP 1.2 41.5  16.3  38.4  2.6  
Sweets 
 
SF 2.6  57.3  13.3  25.7  1.0  
NVP 2.7 44.2  14.1 36.6  2.4  
Juice 
 
SF 2.9  60.4  29.7    6.1  0.5  
NVP 2.5  49.0  33.2  13.5  1.5  
Sugared soft-drink 
 
SF 18.6  41.6    4.7  30.7  4.0  
NVP 14.4  34.6    8.8  35.6  6.2  
 
 
 
Table 3.  Women eating ‘more of’ a food item, n=30,072. 
 
Foods – more of Group n (%)* cOR (95% CI) aOR (95% CI)** 
Milk, cheese SF   5214 (38.0) 1.00 1.00 
 NVP   6816 (41.7) 1.17 (1.12-1.22) 1.15 (1.10-1.21) 
Bread, cereals SF   4411 (32.1) 1.00 1.00 
 NVP   6094 (37.3) 1.26 (1.20-1.32) 1.23 (1.17-1.29) 
Biscuits SF   884 (6.4) 1.00 1.00 
 NVP   2587 (15.8) 2.73 (2.52-2.96) 2.69 (2.48-2.91) 
Fat SF   499 (3.6) 1.00 1.00 
 NVP   768 (4.7) 1.31 (1.17-1.47) 1.28 (1.14-1.43) 
Meat SF   513 (3.7) 1.00 1.00 
 NVP   897 (5.5) 1.50 (1.34-1.67) 1.46 (1.31-1.63) 
Fish SF   2200 (16.0) 1.00 1.00 
 NVP   2793 (17.1) 1.08 (1.02-1.15) 1.07 (1.01-1.14) 
Eggs SF 1035 (7.5) 1.00 1.00 
 NVP   1895 (11.6) 1.61 (1.49-1.74) 1.59 (1.47-1.72) 
Vegetables SF   4430 (32.3) 1.00 1.00 
 NVP   5729 (35.1) 1.13 (1.08-1.19) 1.12 (1.07-1.18) 
Fruit SF   8074 (58.8) 1.00 1.00 
 NVP 10,407 (63.7) 1.23 (1.17-1.29) 1.21 (1.16-1.27) 
Chocolate SF   2428 (17.7) 1.00 1.00 
 NVP   2663 (16.3) 0.91 (0.85-0.96) 0.88 (0.83-0.94) 
Sweets  SF   1830 (13.3) 1.00 1.00 
 NVP   2304 (14.1) 1.07 (0.99-1.14) 1.04 (0.97-1.11) 
Juice SF   4084 (29.7) 1.00 1.00 
 NVP   5419 (33.2) 1.17 (1.12-1.23) 1.16 (1.10-1.22) 
Sugared soft-drink SF   651 (4.7) 1.00 1.00 
 NVP 1438 (8.8) 1.94 (1.76-2.13) 1.92 (1.75-2.11) 
* Number (%) of women with outcome 
** Adjusted for total energy intake 
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Table 4.  Women with ‘reduced intake’ of a food item, n=30,072. 
 
Foods – reduced Group n (%)* cOR (95% CI) aOR (95% CI)** 
Milk, cheese SF   301 (2.2) 1.00 1.00 
 NVP 1518 (9.3) 4.57 (4.03-5.18) 4.70 (4.14-5.33) 
Bread, cereals SF   152 (1.1) 1.00 1.00 
 NVP 1090 (6.7) 6.39 (5.38-7.58) 6.69 (5.63-7.94) 
Biscuits SF   2022 (14.7) 1.00 1.00 
 NVP   3362 (20.6) 1.50 (1.41-1.59) 1.50 (1.41-1.59) 
Fat SF   1974 (14.4) 1.00 1.00 
 NVP   4188 (25.6) 2.05 (1.93-2.18) 2.06 (1.94-2.18) 
Meat SF   665 (4.8) 1.00 1.00 
 NVP   2433 (14.9) 3.44 (3.14-3.76) 3.48 (3.19-3.81) 
Fish SF   448 (3.3) 1.00 1.00 
 NVP   1696 (10.4) 3.43 (3.09-3.82) 3.46 (3.11-3.85) 
Eggs SF   899 (6.5) 1.00 1.00 
 NVP   2444 (15.0) 2.51 (2.32-2.72) 2.53 (2.33-2.74) 
Vegetables SF   120 (0.9) 1.00 1.00 
 NVP   768 (4.7) 5.59 (4.61-6.79) 5.70 (4.69-6.92) 
Fruit SF     75 (0.5) 1.00 1.00 
 NVP   438 (2.7) 5.02 (3.92-6.41) 5.15 (4.03-6.59) 
Chocolate SF   3573 (26.0) 1.00 1.00 
 NVP   6693 (41.0) 1.97 (1.88-2.07) 2.00 (1.91-2.11) 
Sweets  SF   3671 (26.7) 1.00 1.00 
 NVP   6371 (39.0) 1.75 (1.67-1.84) 1.77 (1.69-1.86) 
Juice SF   906 (6.6) 1.00 1.00 
 NVP   2446 (15.0) 2.49 (2.30-2.70) 2.53 (2.33-2.74) 
Sugared soft-drink SF   4761 (34.7) 1.00 1.00 
 NVP   6830 (41.8) 1.35 (1.29-1.42) 1.34 (1.28-1.41) 
* Number (%) of women with outcome 
** Adjusted for total energy intake 
 
 
observed by others (2,5,12,18). Elsewhere it has been 
found that a diet high in carbohydrates may aggravate 
gastric dysrhythmias when compared to high protein 
diets, which can lead to nausea, suggesting that women 
suffering NVP may potentially be exasperating their 
condition by virtue of their dietary choices (19). 
 Popularly craved carbohydrate foods among preg-
nant women in general tend to include biscuits, sweet 
foods, and soft drinks (12,20,21), yet the list also 
includes protein-rich foods such as meat, milk, cheese, 
and eggs (2,7,18,21). Meat is a food item found to be 
both ‘eaten more’ of and ‘eaten less’ of by the NVP 
women in this study. This peculiarity has also been 
reported in other studies (7,21,22). When comparing 
the results for ‘eat more’ and ‘reduced eating’, it is 
evident that a higher proportion of NVP women 
reported they reduced their intake of protein-rich foods 
such as meat, fish, and eggs. This finding supports 
other studies reporting on NVP and diet (7,20,23,24). 
 That the only exception in the ‘eating more’ cate-
gory regarding NVP women should be chocolate is 
somewhat surprising, especially considering the NVP 
group’s prevailingly higher proportions in the other 
food items. We previously found that women with no 
symptoms of nausea and vomiting consumed the most 
chocolate, both in response to a FFQ, and as a response 
to new foods begun since pregnancy (9). Regular 
chocolate consumption has been linked to favorable 
effects upon cardiovascular health, blood pressure, and 
the intestinal immune system (25-27). These benefits 
are attributed to the flavanols and procyanidins, as 
well as other micronutrients found in cocoa. A recent 
study also found cocoa derived flavanols to have a 
prebiotic effect on human gut microflora, whereby the 
cocoa flavanols modulated a significant growth of 
select gut microflora such as Bifidobacterium and 
Lactobacillus species without significant differences in 
the total number of bacteria (28). Supporting this par-
ticipation of intestinal microflora in pregnancy 
wellbeing, the only other food item women without 
symptoms began to consume the most of in our pre-
vious study was dairy-based probiotic foods (9). This 
suggests a possible connection between gut microflora 
and NVP conditions, especially relevant when we 
consider that Helicobacter pylori has previously been 
suggested as causative in symptoms of NVP, as well as 
HG (29). Studies outlining probiotics’ role in prevent-
ing or controlling Helicobacter pylori are growing 
(30). The role of probiotics in the immune system is 
also noteworthy, as symptoms of NVP have been pre-
viously suggested as being triggered by immunological 
changes following conception (31). Probiotics effect 
upon anti- and pro- inflammatory cytokines by modu-
lating the skewness in the balance of T helper cells 
Th1 and Th2, thereby inducing the development of a 
population of T cells producing anti-inflammatory 
152  A. CHORTATOS ET AL. 
 
cytokines, has been previously outlined (31). In vitro 
studies demonstrate cocoa derived flavanols and pro-
cyanidins modulating the release of pro-inflammatory 
cytokines that affect immune system activation (32), 
and recent animal studies have shown cocoa flavono-
ids modulate the immune system via reductions in in-
testinal immunoglobulin A (IgA) concentrations (25). 
 Although speculative, the findings here relating to 
chocolate, when taken in regard with our previous 
findings on chocolate and probiotics, tend to suggest a 
higher intake of these foods may create a more favo-
rable immune response for women with a developing 
conceptus, resulting in an alleviation of NVP symp-
toms. As our findings are based upon a cross-sectional 
study, it is impossible to determine whether these 
dietary patterns for the two groups relating to these 
particular food items are providing a protective effect 
against NVP, although future research would allow a 
more robust hypothesis to be generated. 
 The strengths of this study are the large population-
based cohort the sample has been derived from, and 
the validated FFQ used. A possible weakness of this 
study is the large reliance upon self-reported food 
habits. Bias in recall amongst women with nausea and 
vomiting has also been observed previously and may 
affect some of the results seen here (33). Additionally, 
the responses in the questionnaires do not allow for 
assessing the severity of NVP symptoms. Since many 
of the cited studies have taken place in different 
continents, a degree of cultural or traditional diversity 
may distort the data when compared to a Norwegian 
sample. This is especially relevant in possible reasons 
for changing diet in pregnancy, whether NVP is 
present or not. 
 In conclusion, we have found that the NVP group of 
women experienced a higher degree of dietary change 
compared to the SF group as a result of pregnancy. Of 
the two groups, the NVP women had the lowest pro-
portion ‘eating as before pregnancy’, and highest pro-
portion ‘eating more’ and ‘eating less’ since becoming 
pregnant. The only exception amongst all food items 
surveyed was chocolate, where the SF women had the 
highest proportion ‘eating more’, possibly obtaining 
some protection from NVP symptoms through this 
food. 
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